A large pharmaceutical company had a series of compounds with potential for treatment in prostate cancer.  They asked us to produce a Market Opportunity Map to highlight the various opportunities in this market and allow them to tailor their development programs and sequence their launches appropriately.

A mid-sized biotechnology company had a portfolio of products all focused on orphan diseases.  They wanted to provide access to all patients around the globe, and asked us to evaluate the market access processes not only in leading industrialized markets, but across all countries where there might be significant patient need.